PyInvesting

Market research

3759.HK Pharmaron Beijing Co., Ltd

Current ticker: 3759.HK

HK HKD Healthcare

Latest close

24.90 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
54B
P/E ratio
26.25
Analyst target
39.1804
Dividend yield
0.7%
Beta
0.69

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Pharmaron Beijing Co., Ltd is currently in a long term uptrend where the price is trading 34.1% above its 200 day moving average.

From a valuation standpoint, the stock is 82.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.6.

Pharmaron Beijing Co., Ltd's total revenue sank by 27.0% to $2B since the same quarter in the previous year.

Its net income has dropped by 0.7% to $383M since the same quarter in the previous year.

Finally, its free cash flow grew by 94.5% to $-19M since the same quarter in the previous year.

Based on the above factors, Pharmaron Beijing Co., Ltd gets an overall score of 3/5.